The Federal Trade Commission has accused several drugmakers of violating antitrust laws, via agreements the commission said delayed the U.S. launches of cheaper generic versions of two popular pain treatments.
Mar 31, 2016
0
1
Serelaxin reduces the occurrence of in-hospital worsening heart failure by almost half in patients admitted for acute heart failure, according to the RELAX-AHF trial. The results were presented for the first time today at ...
Sep 2, 2014
0
0
The EU is expected to inflict a heavy fine in the coming days on French drugs giant Servier for colluding to delay a cheaper version of a popular blood-pressure treatment, sources close to the matter told AFP on Tuesday.
Jul 8, 2014
0
0
The Supreme Court is wading into a patent dispute between rival pharmaceutical companies over a multiple sclerosis treatment.
Mar 31, 2014
0
0
Japanese cosmetics maker Kanebo said Monday the number of complaints about skin discolouring from using its whitening products has topped 7,000 from customers both at home and abroad.
Aug 19, 2013
0
0
Pfizer's second-quarter net income more than quadrupled, helped by the sale of its animal health business. The world's second-largest drugmaker beat Wall Street's earnings expectations, though revenue continued to decline ...
Jul 30, 2013
0
0
(AP)—The European Union has fined Danish pharmaceuticals multinational Lundbeck and several other producers a combined 146 million euros ($195 million) for delaying the market entry of cheaper generic alternatives to a ...
Jun 19, 2013
0
0
Two generic drugmakers will pay $2.15 billion to Pfizer and Takeda Pharmaceutical to settle a patent fight over the heartburn treatment Protonix.
Jun 12, 2013
0
0
India, known as the "pharmacy to the world", Monday defended its lucrative generic drug industry as safe and strongly regulated after the nation's biggest drug firm pleaded guilty to US charges of making adulterated medicines.
Jun 3, 2013
0
0
A subsidiary of India's largest pharmaceutical company has agreed to pay a record $500 million in fines and penalties for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown ...
May 13, 2013
0
0
